Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1206Session 2025-2026

What changed between versions

8 paragraphs changed+722 words added−397 removed

Highlighted text was added in the newer version. Struck-through text was removed.

See other bills

under the

same topic

PRINTER'SS1206B1554A03772 NAD:EJH 06/22/26 #90 A03772AMENDMENTS TO SENATE BILL NO. 1554 THE1206Sponsor: GENERALSENATOR ASSEMBLY OF PENNSYLVANIASENATE BILLPENNYCUICKPrinter's No.1206 Session1554Amend Bill, page 1, lines 1 through 6, by striking out all of 2026said INTRODUCEDlines BYand PENNYCUICK,inserting PHILLIPS-HILL, BOSCOLA, TARTAGLIONE, FARRY, J. WARD, VOGEL AND CAPPELLETTI, MARCH 30, 2026 REFERRED TO INSTITUTIONAL SUSTAINABILITY AND INNOVATION, MARCH 30, 2026 AN ACTAmendingAmending the act of December 14, 1992 (P.L.1116, No.145), entitled "An act providing minimum standards, terms and conditions for the licensing of persons who engage in wholesale distributions in interstate commerce of prescription drugs; and making a repeal," further providing for definitions and for license application.TheAmend GeneralBill, Assemblypage 1, lines 9 through 19; page 2, lines 1 through 30; page 3, lines 1 through 11; by striking out all of thesaid Commonwealthlines ofon Pennsylvaniasaid herebypages enactsand asinserting follows:Section 1. The definition of "virtual manufacturer" in section 3 of the act of December 14, 1992 (P.L.1116, No.145), known as the Wholesale Prescription Drug Distributors License Act, added October 16, 2024 (P.L.988, No.101), is amended and the section is amended by adding a definition to read:Section 3. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *"Temporary license." A license issued by the department to a manufacturer or a virtual manufacturer under section 5(a.2) for a drug or medical device that has not yet received final approval from the United States Food and Drug Administration."Virtual manufacturer." A person with a place of business 12345678910111213141516171819located in this Commonwealth in the business of manufacturing and distributing a drug or medical device that:[(1) Holds the drug or device approval and label code or is otherwise identified on the product label from the United States Food and Drug Administration.](1) With respect to the drug or medical device:(i) holds the applicable approval, clearance, authorization or labeler code issued by the United States Food and Drug Administration or is otherwise identified 2026/90NAD/SB1206A03772 - 1 -1234567891011121314151617181920212223242526272829303132333435

located in this Commonwealth in the business of manufacturing and distributing a drug or medical device that:(1) Holds the drug or device approval and label code or is otherwise identified on the product label from the United States Food and Drug Administration[.] or has submitted an application to the United States Food and Drug Administration for approval of the drug or device or intends to submit an application for approval within 12 months.(2) At no time takes physical possession of any drug or device in this Commonwealth.* * *Section 2. Section 5(a) of the act is amended by adding paragraphs to read:Section 5. License application.(a) Information on application.--An applicant for a license shall provide the following information on a license application form approved by the department:* * * (6.2) If the applicant is a manufacturer of a prescription drug that has not been approved by the United States Food and Drug Administration, a statement that the applicant has submitted an application to the United States Food and Drug Administration for approval of the prescription drug or that the applicant intends to submit an application for approval within 12 months. The department may not require approval of a prescription drug by the United States Food and Drug Administration as a condition of licensure under this act.(6.3) If the applicant is a virtual manufacturer that does not hold the drug or device approval and label code or 20260SB1206PN1554 - 2 - 123456789101112131415161718192021222324252627282930

is not otherwise identified on the product label from the United States Food and Drug Administration, a statement that the applicant has submitted an application to the United States Food and Drug Administration for approval of the drug or device or that the applicant intends to submit an application for approval within 12 months. The department may not require approval of a drug or medical device by the United States Food and Drug Administration as a condition of licensure under this act.* * *Section 3. This act shall take effect in 60 days.20260SB1206PN1554 - 3 - 1234567891011

on labeling approved, cleared or authorized by the United States Food and Drug Administration; or(ii) for purposes of a temporary license, has submitted to the United States Food and Drug Administration and has pending before the United States Food and Drug Administration an application, premarket notification, request or other submission seeking approval, clearance or authorization for the drug or medical device.(2) At no time takes physical possession of any drug or device in this Commonwealth.* * *Section 2. Section 5 of the act is amended by adding a subsection to read:Section 5. License application.* * *(a.2) Temporary license.-- (1) If the applicant is a manufacturer of a prescription drug or a virtual manufacturer of a drug or medical device that has not yet received approval from the United States Food and Drug Administration, the department may issue a temporary license if the applicant submits all of the following:(i) Documentation demonstrating that an application for approval has been submitted to the United States Food and Drug Administration, including, where applicable:(A) a new drug application number;(B) an abbreviated new drug application number;(C) a biologics license application number;(D) a unique device identification number;(E) a 510(k) premarket notification; or(F) other documentation acceptable to the department demonstrating active review by the United States Food and Drug Administration.(ii) Documentation identifying any contract manufacturing organization or licensed manufacturing facility involved in the manufacture, packaging, labeling or distribution of the drug or medical device.(iii) Documentation demonstrating compliance with applicable requirements of 21 U.S.C. Ch. 9 Subch. V Pt. H (relating to pharmaceutical distribution supply chain).(2) A temporary license issued under paragraph (1): (i) shall expire one year after issuance unless renewed by the department;(ii) shall automatically expire upon denial, withdrawal or refusal of the applicant's approval application by the United States Food and Drug Administration;(iii) may not authorize commercial distribution of a drug or device unless otherwise permitted under Federal law; and2026/90NAD/SB1206A03772 - 2 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051

(iv) does not create a property interest in the temporary license and may be suspended or revoked by the department for failure to maintain compliance with this act or applicable Federal law.(3) An applicant issued a temporary license under paragraph (1) shall notify the department within five business days of:(i) approval, denial, withdrawal or refusal of an application by the United States Food and Drug Administration; or(ii) any material change to the applicant's manufacturing or distribution arrangements.(4) Issuance of a temporary license or a license under this subsection may not be construed as approval, endorsement or authorization of a drug or medical device by the Commonwealth.(5) The department may promulgate regulations and develop monitoring, reporting and enforcement procedures necessary to implement this subsection.(6) Upon satisfactory proof provided by the temporary licensee to the department that all conditions for licensure have been met, the department shall convert the temporary license into a license within 30 days.(7) The department may not renew a temporary license more than once for the same applicant.* * *Section 3. This act shall take effect in 60 days.2026/90NAD/SB1206A03772 - 3 -123456789101112131415161718192021222324252627

Back to the full text